首页> 外文OA文献 >One-Year Results of Simultaneous Topography-Guided Photorefractive Keratectomy and Corneal Collagen Cross-Linking in Keratoconus Utilizing a Modern Ablation Software
【2h】

One-Year Results of Simultaneous Topography-Guided Photorefractive Keratectomy and Corneal Collagen Cross-Linking in Keratoconus Utilizing a Modern Ablation Software

机译:同时形貌引导的相机切除术和角膜胶原交联的一年结果利用现代消融软件在角蛋白组中交联

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose. To evaluate effectiveness of simultaneous topography-guided photorefractive keratectomy and corneal collagen cross-linking in mild and moderate keratoconus. Methods. Prospective nonrandomized interventional study including 20 eyes of 14 patients with grade 1-2 keratoconus that underwent topography-guided PRK using a Custom Ablation Transition Zone (CATz) profile with 0.02% MMC application immediately followed by standard 3 mw/cm2 UVA collagen cross-linking. Maximum ablation depth did not exceed 58 μm. Follow-up period: 12 months. Results. Progressive statistically significant improvement of UCVA from 0.83±0.37 logMAR preoperative, reaching 0.25±0.26 logMAR at 12 months (P<0.001). Preoperative BCVA (0.27±0.31 logMAR) showed a progressive improvement reaching 0.08±0.12 logMAR at 12 months (P=0.02). Mean Kmax reduced from 48.9±2.8 to 45.4±3.1 D at 12 months (P<0.001), mean Kmin reduced from 45.9±2.8 D to 44.1±3.2 D at 12 months (P<0.003), mean keratometric asymmetry reduced from 3.01±2.03 D to 1.25±1.2 D at 12 months (P<0.001). The safety index was 1.39 at 12 months and efficacy index 0.97 at 12 months. Conclusion. Combined topography-guided PRK and corneal collagen cross-linking are a safe and effective option in the management of mild and moderate keratoconus. Precis. To our knowledge, this is the first published study on the use of the CATz ablation system on the Nidek Quest excimer laser platform combined with conventional cross-linking in the management of mild keratoconus.
机译:目的。评价同时形状引导的光折变形角膜膜切除术和角膜胶原在轻度和中等角蛋白酶中交联的效果。方法。前瞻性非扫描介入研究,包括20名14名14级患者1-2岁的角质蛋白,使用定制消融过渡区(CATZ)型材的地形引导的PRK具有0.02%MMC应用,然后立即进行标准3 MW / CM2 UVA胶原胶原交联。最大消融深度不超过58μm。随访期限:12个月。结果。逐步统计学上显着改善UCVA从0.83±0.37 Logmar术前,达到12个月的0.25±0.26 Logmar(P <0.001)。术前BCVA(0.27±0.31 Logmar)显示逐渐改进达到0.08±0.12 Logmar,在12个月内(P = 0.02)。在12个月内平均降低48.9±2.8至45.4±3.1d(p <0.001),平均kmin从45.9±2.8 d减少到12个月(p <0.003),平均静脉计量不对称从3.01±减少12个月内2.03 d至1.25±1.2 d(P <0.001)。安全指数在12个月内为1.39,12个月疗效指数0.97。结论。组合地形引导的PRK和角膜胶原蛋白交联是一种安全有效的选择,可防止轻度和适度的角蛋白。 precis。据我们所知,这是第一次发表关于在NIDEK Quest Consimer激光平台上使用Catz消融系统的研究,结合了Mild KeratoConus管理中的传统交联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号